Relmada Therapeutics
RLMD
RLMD
113 hedge funds and large institutions have $623M invested in Relmada Therapeutics in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 21 reducing their positions, and 13 closing their positions.
Holders
113
Holders Change
+16
Holders Change %
+16.49%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
29
Increased
41
Reduced
21
Closed
13
Calls
$26.4M
Puts
$13.4M
Net Calls
+$13M
Net Calls Change
+$10.4M
Top Buyers
1 |
CAC
1
Cowen and Company
New York
|
$31.4M |
2 |
2
Citadel Advisors
Miami,
Florida
|
$25.4M |
3 |
3
BlackRock
New York
|
$52.7M |
4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$35.4M |
5 |
RI
5
RTW Investments
New York
|
$68.6M |